Prevalence of AAS‐Positive Samples at Drug Abuse Laboratory Sweden Between 2014 and 2023 and Sub‐Study of Dual Use of AAS and Narcotics
Abstract It is of interest to investigate trends in AAS usage profile. Here we aimed to retrospectively study the prevalence of AAS‐positive samples based on 21,172 consecutive analyses from routine AAS testing 2014–2023. Moreover, 310 urine samples from 2022 to 2023 were reanalyzed for a broader AAS panel as well as for the presence of narcotics. Between 2014 and 2023, the frequency of reported AAS‐positive samples varied between 6% and 11%, with no trend discerned. The prevalence of samples containing
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
